Skip to content

Clinical trials

Completed Brain Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Status: Completed Country / region: South Korea Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20111
20125
20131
20142
20153
20162
20172
20181
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Samsung Medical Center2
Seoul National University Bundang Hospital2
Seoul National University Hospital2
Yonsei University2
Alpha Biopharma (Jiangsu) Co., Ltd.1
AstraZeneca1
Bundang CHA Hospital1
CHA University1
Gangnam Severance Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms22
Glioblastoma5
Carcinoma, Non-Small-Cell Lung4
Gliosarcoma2
Neoplasms2
Wilms Tumor2
Astrocytoma1
Brain Injuries1
Breast Neoplasms1
Central Nervous System Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.